Heart failure pharmacotherapeutics Flashcards
what drug classes are used for removing compensation?
- RAAS inhibitor
- ß-adrenoceptor antagonists (ß-blockers)
- diuretics
- Vasodilators/venodilators
Compensatory mechanisms in chronic/congestive heart failure are intended to
Cause venoconstriction + raise extracellular fluid volume, increasing central venous pressure, diastolic filling pressure and cardiac stretch. Cause vasoconstriction / rise in total peripheral resistance (which increases blood pressure and therefore tissue perfusion pressure). Increase heart rate (tachycardia) and force of contraction.
How is compensation achieved?
- Sympathetic nervous system stimulation (NA and Ad release)
- RAAS activation (AII, aldosterone and ADH release)
What is Sympathetic nervous system stimulation?
Responsible for vasoconstriction + venoconstriction (-vascular adrenoceptors), tachycardia and positive inotropy (cardiac ß-adrenoceptors)
What is RAAS activation
Responsible for vasoconstriction + venoconstriction (vascular AII AT1-receptors + ADH V1-receptors) and salt and fluid retention (renal aldosterone mineralocorticoid type 1 receptors + ADH V2 receptors)
which raas inhibitors are used to remove compensation?
ACE inhibitors (ACEIs) e.g. perindopril, ramipril, captopril, enalapril, lisinopril, quinapril, fosinopril angiotensin II AT1-receptor blockers (ARBs) e.g. candesartan, losartan, valsartan angiotensin receptor neprilysin inhibitors (ARNIs) – sacubitril with valsartan aldosterone receptor blockers e.g. spironolactone, eplerenone
which ß-adrenoceptor antagonists (ß-blockers) are used to remove compensation
specific examples indicated in heart failure e.g. bisoprolol, carvedilol, nebivolol
which diuretics are used to remove compensation
loop diuretics e.g. furosemide, bumetanide, torasemide thiazides and related diuretics e.g. bendroflumethiazide, chlortalidone
which Vasodilators/venodilators are used to remove compensation?
- organic nitrates e.g. glyceryl trinitrate (GTN), isosorbide mononitrate (ISMN), isosorbide dinitrate (ISDN)
- directly acting agents e.g. hydralazine
- alpha-adrenoceptor blockers e.g. prazosin (alpha1-adrenoreceptor selective)
what are positive inotropes
Positive inotropes strengthen the heart’s contractions, so it can pump more blood with fewer heartbeats. This medicine is usually given to patients with congestive heart failure or cardiomyopathy. These medicines may also be given to patients who have had a recent heart attack.
list the drugs used to achieve positive inotropy in the heart.
- Cardiac glycosides e.g. digoxin
- ß-adrenoceptor agonists e.g. dobutamine, dopamine
- Phosphodiesterase type III (PDE III) inhibitors e.g. milrinone, enoximone
explain the actions of Cardiac glycosides as a positive inotrope
inhibit Na/K-ATPase in cardiac sarcolemma to ultimately cause increased calcium accumulation in sarcoplasmic reticulum available for calcium-induced calcium release and myocardial contraction
explain the actions of ß-adrenoceptor agonists as a positive inotrope
- ß-sympathomimetic agents
- cardiac ß1-adrenoceptor signalling leads to raised cAMP and increased force of contraction
explain the actions of Phosphodiesterase type III (PDE III) inhibitors as a positive inotrope
- inhibit enzyme (PDE III) responsible for metabolising cardiac cAMP, thus raising myocardial cAMP and force of contraction
- also raise cAMP in blood vessels, leading to vaso- and venodilation
- known as inodilators in respect of these multiple cardiac and vascular effects
fill this in